Alzheimer’s Research UK has welcomed a call from the World Dementia Envoy, Dr Dennis Gillings, for international action to secure new investment in dementia research. Dr Gillings will make the call at today’s Global Dementia Legacy Event on Finance and Social Impact Investment in Dementia – the first of four worldwide legacy events following the G8 dementia summit.
The event, which is being held in London, will see experts from across the globe explore ways to increase investment in dementia research. It follows an ambition that was set out by G8 countries in December to find a cure or disease modifying treatment by 2025.
Rebecca Wood, Chief Executive of Alzheimer’s Research UK, said:
”Alzheimer’s Research UK is uniquely well placed to respond to Dr Gillings’ challenge to reignite dementia research and development. Planned investment through our Defeat Dementia campaign will feed innovative academic discoveries into the drug development pipeline, helping treatments to reach people with dementia more quickly. It’s imperative that efforts to remove regulatory barriers are successful to allow new dementia research partnerships to thrive and deliver on their promise.”
For more information, see our blog: Defeat Dementia
Posted in Policy news